Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. This work examines the impact of each at-home glucose-lower
Reviewers: Susanna Hofmann (Helmholtz Diabetes Center) | 📗📗📗📗◻️ • L Marie (Albert Einstein Medical Center) | 📒📒📒◻️◻️
To read the original manuscript, click the link above. To read the reviews, click the links below.